Description

Curious how a leading physician scientist is on the forefront of breakthrough drug development? Have questions? Come attend the American Physician Scientists Association’s next Interactive Session, where we will host a fireside chat with leading physician scientist Jeffrey Leiden, MD, PhD. Dr. Leiden will be available to share more about his career experience, spanning all aspects of the biotech and pharmaceutical industries, and to answer your questions!

Remarkably, he has dedicated the past 40 years of his career to improving the lives of people with serious diseases, leading collaborations that developed the first CRISPR/Cas9 gene-edited therapy approved for certain eligible people with sickle cell disease and transfusion-dependent beta thalassemia as well as the first potentially curative stem cell-based therapy for type 1 diabetes.

The webinar is on February 26, 2026, at 7pm ET, completely FREE, and open to all. Register here (https://tinyurl.com/APSAWebinars) to attend this session. For more information, as well as an application FAQ document, please visit our website.